Counterpoint Mutual Funds LLC Sells 60,154 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Counterpoint Mutual Funds LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 43.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 78,668 shares of the pharmacy operator's stock after selling 60,154 shares during the quarter. Counterpoint Mutual Funds LLC's holdings in Walgreens Boots Alliance were worth $734,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of WBA. State Street Corp lifted its holdings in Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator's stock valued at $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after buying an additional 2,185,950 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator's stock valued at $68,046,000 after acquiring an additional 817,762 shares during the period. Thompson Siegel & Walmsley LLC lifted its position in shares of Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator's stock valued at $62,325,000 after acquiring an additional 934,754 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Walgreens Boots Alliance by 9.6% in the fourth quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator's stock worth $50,684,000 after acquiring an additional 478,061 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

Several research firms have weighed in on WBA. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research note on Tuesday. They issued a "hold" rating on the stock. Bank of America raised their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Trading Down 0.2 %

Shares of WBA traded down $0.02 during midday trading on Friday, hitting $11.10. The stock had a trading volume of 37,249,707 shares, compared to its average volume of 20,716,269. The stock's 50 day moving average is $10.97 and its 200 day moving average is $9.81. The firm has a market cap of $9.59 billion, a PE ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the company posted $0.66 EPS. The firm's revenue for the quarter was up 7.6% on a year-over-year basis. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.